References
- Reinberg A., Smolensky M. H. Circadian changes of drug disposition in man. Clin Pharmacokinet 1982; 7: 401–420
- Haus E., Halberg F., Kuhl J. F. W., Lakatua D. J. Chronopharmacology in animals. Chronobiological Aspects of Endocrinology., J. Aschoff, F. Ceresa, F. Halberg. Schattauer, Stuttgart 1974; 269–304
- Nakano S., Nagai K., Ogawa N. Role of feeding schedule and pharmacokinetics in chronopharmacology of drugs acting on the central nervous system. Annu Rev Chronopharmacol 1984; 1: 263–266
- Nakano S., Ohdo S., Ogawa N. Manipulation of feeding schedule can modify the circadian rhythms of toxicity and kinetics of theophylline in mice. Annu Rev Chronopharmacol 1988; 5: 317–320
- Nakano S., Ogawa N. Chronotoxicity of gentamycin in mice. IRCS Med Sci 1982; 10: 592–593
- Nakano S., Hara C., Ogawa N. Circadian rhythm of apomorphine-induced stereotypy in rats. Pharmacol Biochem Behav 1980; 12: 459–461
- Ohdo S., Nakano S., Ogawa N. Chronopharmacological study of sodium valproate in mice: dose-concentration- response relationship. Japan J Pharmacol 1988; 47: 11–19
- Melander A. Influence of food on the bioavailability of drugs. Clin Pharmacokinet 1978; 3: 337–351
- Vachon C., Savoie L. Circadian variation of food intake and digestive tract contents in the rat. Physiol Behav 1987; 39: 629–632
- LÖScher W. Rapid determination of valproate sodium in serum by gas-liquid chromatography. Epilepsia 1977; 18: 225–227
- Nagayama H., Takagi A., Sakurai Y., Yoshimoto S., Nishiwaki K., Takahashi R. Studies on circadian susceptibility rhythm to haloperidol. Folia Pharmacol Japan 1978; 74: 951–957, (Abstr. In English)
- Nagayama H., Takagi A., Sakurai Y., Nishiwaki K., Takahashi R. Chronopharmacological study of neuroleptics– II. Circadian susceptibility rhythm to chlorpromazine. Psychopharmacology (Berlin) 1978; 58: 49–53
- Steiman G. S., Woerpel R. W., Sherard E. S., Jr. Treatment of accidental sodium valproate overdose with an opiate antagonist. Ann Neurol 1979; 6: 274
- Dingledine R., Iversen L. L., Breuker E. Naloxone as a GABA antagonist: evidence from intophoretic, receptor binding and convulsant studies. Eur J Pharmacol 1978; 47: 19–27
- LÖScher W. Anticonvulsant activity of metabolites of valproic acid. Arch Int Pharmacodyn 1981; 249: 158–163
- Kesterson J. W., Granneman G. R., Machinist J. M. The hepatotoxicity of valproic acid and its metabolites in rats– 1: toxicologic, biochemical and histopathologic studies. Hepatology 1984; 4: 1143–1152
- Nau H., Loscher W. Valproic acid and metabolites: pharmacological toxicological studies. Epilepsia 1984; 25: 14–22
- Nakano S., Watanabe H., Ohdo S., Ogawa N. Circadian stage-dependent changes in diazepam and valproate kinetics in man: a single and repetitive administration study. Annu Rev Chronopharmacol 1986; 3: 421–424
- Watanabe H., Nakano S., Nagai K., Ogawa N. Time-dependent absorption of theophylline in man. J Clin Pharmacol 1984; 24: 509–514
- Nakano S., Hollister L. E. Chronopharmacology of amitriptyline. Clin Pharmacol Ther 1983; 33: 453–459
- Nakano S., Watanabe H., Nagai K., Ogawa N. Circadian stage dependent changes in diazepam kinetics. Clin Pharmacol Ther 1984; 36: 271–277
- Holcslaw T. L., Miya T. S., Bousquet W. S. Circadian rhythms in drug action and drug metabolism in the mouse. J Pharmacol Exp Ther 1975; 195: 320–332
- Soliman K. F. A., Gipson K., Owasoyo J. O., Kirksey O., Walker C. A. Diurnal variation in the alcohol dehydrogenase activity of rat brain and liver. Res Commun Subst Abuse 1982; 3: 225–228
- Minors D. S., Waterhouse J. M. Aspects of chronopharmacokinetics and chronergy of ethanol in healthy man. Chronobiologia 1980; 7: 465–480
- Clench J., Reinberg A., Dziewanowska Z., Ghata J., Smolensky M. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur J Clin Pharmacol 1981; 20: 359–369
- Turnbull D. M., Rawlins M. D., Weightman D., Chadwick D. W. Plasma concentrations of sodium valproate: their clinical value. Ann Neurol 1983; 14: 38–42
- May T., Rambeck B. Serum concentrations of valproic acid: influence of dose and comedication. Ther Drug Monit 1985; 7: 387–390